Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-04

Clinical Trial Update: Triamcinolone Injections for Persistent Choroidal Effusions Post Glaucoma Surgery [Phase 4]

View source ↗

Summary

A Phase 4 trial investigating Triamcinolone injections for persistent choroidal effusions after glaucoma surgery.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Triamcinolone (triamcinolone)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Glaucoma, Choroidal Effusions | Phase 4 | Status: UNKNOWN